AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 1 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,913,677 | -42.5% | 5,629,103 | 0.0% | 2.51% | -51.4% |
| Q2 2023 | $62,426,752 | -11.5% | 5,629,103 | +22.6% | 5.17% | -37.5% |
| Q1 2023 | $70,502,028 | -25.9% | 4,592,966 | +7.1% | 8.28% | -16.8% |
| Q4 2022 | $95,158,841 | +53.8% | 4,288,366 | +13.2% | 9.95% | +68.1% |
| Q3 2022 | $61,864,000 | +88.0% | 3,788,366 | +67.3% | 5.92% | +86.3% |
| Q2 2022 | $32,898,000 | – | 2,264,150 | – | 3.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |